Literature DB >> 766879

Vaccination of schoolgirls against rubella. Assessment of serological status and a comparative trial of Wistar RA 27/3 and Cendehill strain live attenuated rubella vaccines in 13-year-old schoolgirls in Dudley.

D S Freestone, G M Reynolds, J A McKinnon, J Prydie.   

Abstract

A total of 1525 schoolgirls aged 13 years from 21 schools in the County Borough of Dudley, were bled for titration of rubella haemagglutinating inhibiting antibody and then were immediately vaccinated with either Wistar RA 27/3 or Cendehill strain live attenuated. Both vaccines were administered subcutaneously by syringe and needle but the Wistar RA 27/3 vaccine was also given by multiple injection apparatus. Significnatly higher conversion rates and geometric mean haemagglutinating inhibiting antibody titres were obtained in girls initially seronegative given the Wister RA 27/3 than in those given the Cendehill vaccine, regardless of the method of vaccination. The RA 27/3 strain was associated with a small but significantly greater incidence of local pain immediately on injection. With this exception, differences in the occurrence of reactions were not found between vaccines, between those initially susceptible and immune or with the level of antibody response.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 766879      PMCID: PMC478923          DOI: 10.1136/jech.29.4.258

Source DB:  PubMed          Journal:  Br J Prev Soc Med        ISSN: 0007-1242


  8 in total

1.  Comparative trial of HPV-77, DE-5 and RA 27-3 live-attenuated rubella vaccines.

Authors:  R B Wallace; P Isacson
Journal:  Am J Dis Child       Date:  1972-10

2.  Programmes for the prevention of rubella during pregnancy by active immunization.

Authors:  D S Freestone
Journal:  Br J Prev Soc Med       Date:  1974-11

3.  Antibody response in serum and nasopharynx after naturally acquired and vaccine-induced infection with rubella virus.

Authors:  P L Ogra; D Kerr-Grant; G Umana; J Dzierba; D Weintraub
Journal:  N Engl J Med       Date:  1971-12-09       Impact factor: 91.245

Review 4.  Rubella: the challenge of its control.

Authors:  D M Horstmann
Journal:  J Infect Dis       Date:  1971-06       Impact factor: 5.226

5.  Attenuation ob rubella virus by serial passage in primary rabbit kidney cell cultures. I. Growth characteristics in vitro and production of experimental vaccines at different passage levels.

Authors:  J Peetermans; C Huygelen
Journal:  Arch Gesamte Virusforsch       Date:  1967

6.  Attenuation of rubella virus by serial passage in primary rabbit kidney cell cultures. II. Experiments in animals.

Authors:  C Huygelen; J Peetermans
Journal:  Arch Gesamte Virusforsch       Date:  1967

7.  Precipitin responses to rubella vaccine RA 27-3.

Authors:  G L Le Bouvier; S A Plotkin
Journal:  J Infect Dis       Date:  1971-02       Impact factor: 5.226

8.  Studies of immunization with living rubella virus. Trials in children with a strain cultured from an aborted fetus.

Authors:  S A Plotkin; D Cornfeld; T H Ingalls
Journal:  Am J Dis Child       Date:  1965-10
  8 in total
  7 in total

1.  Medical research: cell division.

Authors:  Meredith Wadman
Journal:  Nature       Date:  2013-06-27       Impact factor: 49.962

2.  Relationship between HLA polymorphisms and gamma interferon and interleukin-10 cytokine production in healthy individuals after rubella vaccination.

Authors:  Inna G Ovsyannikova; Robert M Jacobson; Jenna E Ryan; Neelam Dhiman; Robert A Vierkant; Gregory A Poland
Journal:  Clin Vaccine Immunol       Date:  2007-01-10

3.  Polymorphisms in the Wilms Tumor Gene Are Associated With Interindividual Variations in Rubella Virus-Specific Cellular Immunity After Measles-Mumps-Rubella II Vaccination.

Authors:  Emily A Voigt; Iana H Haralambieva; Beth L Larrabee; Richard B Kennedy; Inna G Ovsyannikova; Daniel J Schaid; Gregory A Poland
Journal:  J Infect Dis       Date:  2018-01-30       Impact factor: 5.226

4.  Polymorphisms in HLA-DPB1 are associated with differences in rubella virus-specific humoral immunity after vaccination.

Authors:  Nathaniel D Lambert; Iana H Haralambieva; Richard B Kennedy; Inna G Ovsyannikova; Vernon Shane Pankratz; Gregory A Poland
Journal:  J Infect Dis       Date:  2014-10-06       Impact factor: 5.226

Review 5.  Prevention of congenital rubella.

Authors:  J P Welch
Journal:  Can Med Assoc J       Date:  1977-07-23       Impact factor: 8.262

6.  Antibody titres in women six to eight years after the administration of RA2713 and Cendehill rubella vaccines.

Authors:  H Macdonald; J O Tobin; J E Cradock-Watson; J Lomax
Journal:  J Hyg (Lond)       Date:  1978-06

7.  Rubella in Orkney: seroepidemiology and vaccination.

Authors:  M A Moffat; S N Heywood; E Laughton; J J Gould; D S Freestone
Journal:  J Hyg (Lond)       Date:  1977-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.